Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
- Correction to: Prostate Cancer and Prostatic Diseases https://doi.org/10.1038/s41391-021-00395-4, published online 30 May 2021
Download full text files
Additional Services
| Author: | Mike WenzelORCiDGND, Luigi NoceraORCiD, Claudia Collà RuvoloORCiD, Christoph WürnschimmelORCiDGND, Zhe Tian, Shahrokh F. ShariatORCiDGND, Fred SaadORCiDGND, Derya TilkiORCiDGND, Markus GraefenORCiDGND, Luis KluthORCiDGND, Alberto BrigantiORCiD, Philipp MandelORCiDGND, Francesco MontorsiGND, Felix ChunORCiDGND, Pierre I. Karakiewicz |
|---|---|
| URN: | urn:nbn:de:hebis:30:3-752977 |
| DOI: | https://doi.org/10.1038/s41391-023-00656-4 |
| ISSN: | 1476-5608 |
| Publisher: | Stockton Press |
| Place of publication: | Basingstoke |
| Document Type: | Article |
| Language: | English |
| Date of Publication (online): | 2023/03/10 |
| Date of first Publication: | 2023/03/10 |
| Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
| Release Date: | 2024/07/18 |
| Volume: | 26.2023 |
| Page Number: | 2 |
| First Page: | 1 |
| Last Page: | 2 |
| Note: | Korrektur zu: Wenzel, M., Nocera, L., Collà Ruvolo, C. et al. Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. Prostate Cancer Prostatic Dis (2023). https://doi.org/10.1038/s41391-023-00656-4 |
| Institutes: | Medizin / Medizin |
| Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
| Sammlungen: | Universitätspublikationen |
| Licence (German): |  Creative Commons - CC BY - Namensnennung 4.0 International |
